Wedbush Predicts Weaker Earnings for Xenon Pharmaceuticals
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Equities researchers at Wedbush dropped their FY2028 earnings per share (EPS) estimates for Xenon Pharmaceuticals in a research report issued to clients and investors on Friday, February 28th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings of $1.22 per share for the […]
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Equities researchers at Wedbush dropped their FY2028 earnings per share (EPS) estimates for Xenon Pharmaceuticals in a research report issued to clients and investors on Friday, February 28th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings of $1.22 per share for the […]
